Holen Sie sich die Stockscreener-App
52.37
2.96%
-1.60
Apogee Therapeutics Inc Aktie (APGE) Neueste Nachrichten
How to integrate Apogee Therapeutics Inc. into portfolio analysis toolsRate Hike & Low Drawdown Investment Strategies - newser.com
Does Apogee Therapeutics Inc. (APGE) Have the Potential to Rally 72.52% as Wall Street Analysts Expect? - Yahoo Finance
How moving averages guide Apogee Therapeutics Inc. trading2025 Trading Volume Trends & Real-Time Buy Signal Notifications - newser.com
Will Apogee Therapeutics Inc. stock split attract more investorsJuly 2025 Selloffs & AI Forecast for Swing Trade Picks - newser.com
Using data filters to optimize entry into Apogee Therapeutics Inc.Exit Point & Fast Gaining Stock Strategy Reports - newser.com
Best Biotech Stocks To ConsiderOctober 9th - MarketBeat
Real time scanner hits for Apogee Therapeutics Inc. explainedMarket Movers & AI Driven Stock Reports - newser.com
Is it time to cut losses on Apogee Therapeutics Inc.July 2025 Short Interest & Capital Efficiency Focused Strategies - newser.com
Technical signs of recovery in Apogee Therapeutics Inc.Trade Volume Summary & Reliable Volume Spike Trade Alerts - newser.com
Apogee Therapeutics (NASDAQ:APGE) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat
Apogee Therapeutics closes $345 million public offering By Investing.com - Investing.com Nigeria
Apogee Therapeutics Raises $345 Million From Public Offering - MarketScreener
Apogee Therapeutics Closes $345 Million Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $345 Million - GlobeNewswire
$345M Raised — Apogee Therapeutics Closes Offering of 8.05M Shares Including Pre-Funded Warrants - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Given "Buy" Rating at BTIG Research - MarketBeat
What’s the recovery path for long term holders of Apogee Therapeutics Inc.Swing Trade & Weekly High Conviction Ideas - newser.com
Does Apogee Therapeutics' (APGE) $300 Million Raise Mark a Shift in Its R&D Ambition? - Yahoo Finance
Apogee Therapeutics (APGE): Assessing Valuation Following $300 Million Equity Raise - Yahoo Finance
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq By Investing.com - Investing.com Nigeria
Apogee Therapeutics raises $323.3 million in public offering on Nasdaq - Investing.com India
Apogee Therapeutics Raises $323.3 Million in Offering - TipRanks
Published on: 2025-10-10 05:23:46 - newser.com
Form 424B5 Apogee Therapeutics, - StreetInsider
Reversal indicators forming on Apogee Therapeutics Inc. stockQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Apogee Therapeutics' (APGE) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Why Apogee Therapeutics Stock Triumphed on Thursday - The Globe and Mail
Why Apogee Therapeutics Stock Triumphed on Thursday - The Motley Fool
Delta Air Lines, Costco rise premarket; Apogee Therapeutics slips - Investing.com
Delta Air Lines, Tilray Brands, UiPath, Akero Therapeutics, Apogee Therapeutics: Stocks Making The Biggest Moves Today - Stocktwits
Delta Air Lines, Costco rise premarket; Apogee Therapeutics slips By Investing.com - Investing.com Australia
Helen of Troy, Ferrari, Apogee Therapeutics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Biggest stock movers Thursday: TLRY, AKRO, DAL, and more (APGE:NASDAQ) - Seeking Alpha
Why Richardson Electronics Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket - Benzinga
Published on: 2025-10-09 03:41:55 - newser.com
Apogee Therapeutics prices $300 million public offering By Investing.com - Investing.com Australia
Apogee Therapeutics prices $300 million public offering - Investing.com
Apogee Therapeutics, Inc. announces pricing of $300 million underwritten public offering - MarketScreener
$300M Offering: Apogee Therapeutics Prices 6.95M Shares; Includes Pre-funded Warrants Exercisable Immediately - Stock Titan
Apogee Therapeutics, Inc. Announces Pricing of $300 Million Underwritten Public Offering - Yahoo Finance
Apogee Therapeutics launches common stock public offering By Investing.com - Investing.com Nigeria
Apogee Therapeutics announces proposed underwritten public offering - MarketScreener
Apogee Therapeutics stock falls after announcing proposed public offering By Investing.com - Investing.com Canada
Apogee Therapeutics Launches Public Offering - MarketScreener
Apogee Therapeutics drops on stock offering launch - TradingView
Apogee Therapeutics launches common stock public offering - Investing.com
Apogee Therapeutics, Inc. Announces Underwritten Public Offering of Common Stock and Pre-Funded Warrants - Quiver Quantitative
Apogee Therapeutics, Inc. Announces Proposed Underwritten Public Offering - GlobeNewswire
15% Overallotment Option — Apogee Therapeutics Commences Public Offering to Fund Trials - Stock Titan
Apogee Therapeutics (NASDAQ:APGE) Trading Up 6.9%Here's What Happened - MarketBeat
Published on: 2025-10-05 04:04:42 - newser.com
What analysts say about Apogee Therapeutics Inc stockStock Split Announcements & In-Depth Analyst Ratings Explained Simply - earlytimes.in
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):